baber/WOPTO huggingface dataset:
Patent SG-1295-G (SG)
Title: 4-methyl-1-pentene polymer compositions
Inventor: SHIGEMORI HIROMI
IPC: C08K3/00
Filed: 1995-01-05
Abstract: In accordance with the present invention, there are provided 4-methyl-1-pentene polymer compositions comprising 90-10 parts by weight of 4-methyl-1-pentene polymer (A) 90-10 parts by weight of propylene polymer (B) and 70-10 parts by weight of inorganic filler (C), provided that the sum of (A), (B) and (C) total to 100 parts by weight. There are also provided 4-methyl-1-pentene polymer compositions comprising 20-3 parts by weight of  alpha -olefin copolymer (D) in addition to the above-mentioned components (A), (B) and (C), provided that the sum of (A), (B), (C) and (D) totals to 100 parts by weight. These compositions as illustrated above are capable of vacuum forming, injection blow-forming and the like, and they are excellent in rigidity at high temperatures, toughness at low temperatures and impact strength.
Patent IE-39745-L (IE)
Title: 3, 3- ethylenedioxy- gon -9- en -11- ones.
IPC: C07J1/00
Filed: 1974-01-04
Abstract: 1451721 11-Oxygenated steroids ROUSSEL UCLAF 4 Jan 1974 [5 Jan 1973] 00354/74 Heading C2U The invention comprises compounds I infra, their preparation from compounds II-VII and their conversion into compounds VIII-X R = Me, Et, Pr ; R<SP>1</SP> = C 1-3 alkyl ; R<SP>2</SP>=oxo, ketal or (H, #-OR<SP>3</SP>); R<SP>3</SP>=H or C 1-12 carboxylic acyl; R<SP>4</SP>=ketal or (H, #-OR<SP>3</SP>); R<SP>5</SP>=oxo or (H, #- OR<SP>3</SP>); X=H or OH; Y=C 1-4 alkyl or haloalkyl ; W=H or OCOY; Z = H or #<SP>4</SP>-unsaturation. Reagents: II # III epoxidizing agent; III # IV Lewis acid; IV # I(X=H), e.g. alumina or alkali metal base; IV # V epoxidizing agent; V # I(X=OH) strong base; IV # VI, e.g. alkali metal alcoholate; VI # VII epoxidizing agent; VII # I(X=OH) alkaline agent; I(R<SP>2</SP>=oxo) # I(R<SP>2</SP>=ketal), e.g. ethylene glycol or specified dioxolanes I(R<SP>2</SP> = R<SP>4</SP>) # VIII RMgHal, then functional deriv. of YCO 2 H; VIII (W=H) # IX (Z = H) acid then base; VIII (W = OCOY) # IX (Z = #<SP>4</SP>) acid; I(X = α-H; R<SP>2</SP>=R<SP>4</SP>) # X RMgHal; X # IX (10α-R; Z=a-H) acid.
[GB1451721A]
Patent IE-900408-L (IE)
Title: Dental Filling Material
IPC: A61K6/896
Filed: 1990-02-05
Abstract: The invention relates to a dental filling material containing at least one polymerizable (meth)acrylic acid ester, characterized in that it contains 20 to 90 % by weight, calculated on the total composition, of a compound consisting of the structural element E2 and at least one of the structural elements E1 and/or E3 and/or E4 of the general formula <CHEM> where R1 denotes a methyl, ethyl, n-propyl, isopropyl or an unsubstituted or CH3-C3H7-substituted phenyl radical, R2 denotes a CH2=CH-, CH2=CHCOO(CH2)n- or <CHEM> radical or R1, n denotes 0, 1, 2 or 3, and M denotes titanium or zirconium.
[EP0381961A2]
Patent IE-810552-L (IE)
Title: Purines
IPC: C07F9/38
Filed: 1981-03-13
Abstract: There are prepared compounds of the formulawhere R<sup>1</sup> is alkyl of 1 to 8 carbon atoms and R<sup>2</sup> is the ester group of an unsubstituted monocarboxylic acid, aromatic carboxylic acid, aminocarboxylic acid, unsubstituted dicar. boxylic acid. phosphoric acid. or nitric acid or a glycoside or an acetaldehyde acetal The compounds are immunomodulators. have antiviral activity and antitumor activity and also are enzyme inhibitors. The compounds can also be used to introduce the corresponding alcohol into biological systems, in some cases with enhanced potency.
Patent FI-853047-L (FI)
Inventor: MOILANEN MATTI J
IPC: B08B/
Filed: 1985-08-08
Abstract: Local extraction device, which prevents compounds that are formed at a point of working or the like from being spread to the surroundings. The significance of the device claimed resides in the fact that the device essentially reduces gases, fumes and vapours that are formed and spread by plasma and gas-shielded machines and are harmful to workers. The device does not obstruct the worker's clear view of the object being machined and does not make it more difficult to define the position of the seam and the machining point. Nor does the device make actual working more difficult or reduce the rate of working. The device comprises a pressure and suction duct system, which together with an integral or separate sucker removes pollutants from a space defined by an air curtain. The prevention of the spread of pollutants is characterized in that a convergence of opposing jets 5 is achieved, together with a state of equilibrium between the outwardly directed jet blowing the pollutants away from the machining point and the jet directed via the surface of the work piece, which is achieved by the local diversion device. Since the jets, which in the convergence 5 have prevented one another from advancing, can be freely disengaged only towards the workpiece, they have already largely mixed the gases that are then diverted in the same direction of movement as is induced by a suction duct, which through its suction produces a balanced flow in the said defined space. <IMAGE>
Patent IE-41047-L (IE)
Title: Method for insecticide use
IPC: A01N53/08
Filed: 1975-05-07
Abstract: 1511646 Pesticidal application of cyclopropane carboxylates WELLCOME FOUNDATION Ltd 7 May 1975 [8 May 1974] 20224/74 Heading A5E A method of treating domestic mammals (e.g. cattle, sheep or horses) for the prevention or minimisation of infestation by insects of the order Diptera comprises application to the mammals of a non-toxic, infestation prevention or minimisation effective amount of 3- phenoxybenzyl-2, 2-dimethyl-3-(2, 2-dichlorovinyl) cyclopropane-1-carboxylate or a formulation thereof. Application may be as a dip, spray, foam, dust, paste, grease or pour-on formulation.
[GB1511646A]
Patent IE-801057-L (IE)
Title: 1Ó-3ß-DIHYDROXY-27-NOR-CHOLESTA-5-EN AND 5,7-DIEN-25-ONE
IPC: A61K31/59
Filed: 1980-05-21
Abstract: New vitamin D derivatives as well as new intermediate compounds derived during the processes for preparing such new derivatives. The new derivatives have been identified as 1//c-hydroxy-25-keto-27-nor-vitamin D<u3>u and its acylates. 1//c-hydroxy-25-keto-27-nor-vitamin D<u3>u expresses excellent vitamin D-like activity and would find ready application as a substitute for vitamin D compounds in the treatment of disease states evincing calcium-phosphorous imbalance. 
[WO8002502A1]
Patent IE-41886-L (IE)
Title: Manufacture of foamed thermoplastic
IPC: B29C48/92
Filed: 1975-06-04
Abstract: 1470267 Extruding longitudinally oriented foamed sections SOC CHIMIQUE DES CHARBONNAGES 3 June 1975 [5 June 1974] 23958/75 Heading B5A [Also in Division C3] A foamed thermoplastics section, having a ratio of density to that of the unfoamed material of 0À4 to 0À9, and which is oriented and has cells which are elongate, in the direction of the longitudinal axis of the section, is produced by extruding the thermoplastics containing the blowing agent at a temperature corresponding to the "rubbery flow" region, D, Fig. 1, cooling the extrudate around its periphery immediately at the outlet of the die and to a temperature of the "rubbery plateau", C, and drawing it through a metallic sizing die and a following cooling zone, with the extrusion and sizing die passages corresponding in shape and size to that of the section, and the ratio of extrusion speed to that at which the section is drawn from the sizing die corresponding to the density ratio of the section. The process requires an elongation of the order of 100% of the surface regions of the extrudate, obtained by the cooling to a temperature of the "rubbery plateau" of the material. For density ratios of 0À4 to 0À6, the temperature of the remainder of the extrudate may be that of the rubbery flow region, D. The peripheral cooling is preferably effected by jets of cold fluid directed at pressures which may be constant around the periphery in the case of a circular section rod, or may vary around the periphery, as in Specification 1,450,990, for sections such as that of the example, Fig. 2, where a specified foamable polystyrene homopolymer composition is extruded from the die P, and cooled by jets 1-7. The thermoplastics may also comprise polyvinyl chloride or polystyrene, or copolymers comprising one thereof.
[GB1470267A]
Patent IE-791448-L (IE)
Title: Dry etching process using plasma.
IPC: H01L21/302
Filed: 1979-08-08
Abstract: Plasma etching as applied to many of the materials encountered in the fabrication of LSI's is complicated by loading effect-the dependence of etch rate on the integrated surface area to be etched. This problem is alleviated by appropriate choice of etchant and etching conditions. Appropriate choice of system parameters, generally most concerned with the inherent lifetime of etchant species, may also result in improvement of etch rate uniformity on a wafer-by-wafer basis.
[US4226665A]
Patent IE-34833-L (IE)
Title: Recovery of lead and silver
IPC: C01G9/00
Filed: 1970-12-22
Abstract: 1337739 Recovery of lead and silver ASTURIANA DE ZINC SA 26 Nov 1970 [22 Dec 1969] 56207/70 Heading C1A Lead and silver contained in the residues remaining after zinc-containing concentrates have been roasted and treated with acid to dissolve zinc, by leaching the residues at ambient temperature with an acidified solution containing chloride ions. The solution is preferably a saturated solution of NaCl acidified with HCl. If H 2 SO 4 is used to acidify the solution, CaCl 2 is preferably added to precipitate the sulphate as CaSO 4 . CuCl may be added to the solution to promote oxidation of sulphides in the residue. The silver and lead may be recovered from the solution by precipitation as sulphides, or by consectuive cementation. Silver may be precipitated by cementation with lead, and the lead then obtained by cementation with zinc. The zinc may then be recovered as an insoluble salt, washed free of chloride and recycled.
[GB1337739A]
Patent IE-43506-L (IE)
Title: Isoquinolines
IPC: A61K/
Filed: 1976-07-28
Abstract: 1504424 Isoquinoline derived aminoethers BEECHAM GROUP Ltd 5 Aug 1976 [9 Aug 1975] 33283/75 Heading C2C The invention comprises compounds of formula and salts thereof wherein R 1 is a C 1-6 alkyl, C 3-6 cycloalkyl phenyl, naphthyl, aralkyl, substituted phenyl or substituted naphthyl group; R 2 is a group: wherein R 6 is a hydrogen atom or a C 1-6 alkyl group, R 7 is a hydrogen atom or a C 1-6 alkyl, phenyl, tolyl, or benzyl group or R 6 is linked to R 7 so that the NR 6 R 7 moiety is a 5-, 6- or 7- membered ring, R 8 is a hydrogen atom or a C 1-4 alkyl group or is joined to R 6 to form part of a morpholino ring and R 9 and R 10 are each hydrogen atoms or C 1-4 alkyl groups; R 3 is a hydrogen atom or a C 1-6 alkyl or a trifluoromethyl group; R 4 is a hydrogen atom or a C 1-6 alkyl, benzyl or phenyl group or an acyl group containing from 2 to 7 carbon atoms and R 5 is a hydrogen atom or a C 1-6 alkyl group. In examples, these compounds are prepared by (1) reacting a 7-methoxy-2,3-dihydroisoquinolin - 4(1H) - one with R 1 -Li to give a 4 - R 1 - 7 - methoxy - 1,2,3,4 - tetrahydroisoquinolin - 4 - ol, treating the latter with ethanolic HCl followed by NaBH 4 to give the 4 - R 1 - 7 - methoxy - 1,2,3,4 - tetrahydroisoquinoline, optionally reacting with CH 2 O followed by H 2 /Raney Ni so as to introduce a 2- methyl group, treating with HBr to afford the 7-hydroxy analogue and etherifying with an R 2 - containing reagent; (2) reacting the 7- glycidyloxy analogue with R 6 R 7 NH; or (3) hydrogenolysing the R 7 = benzyl group to R 7 = H; or (4) separating optical isomers. Therapeutic compositions comprise the above tetrahydroisoquinolines, and may be administered orally or parenterally.
[GB1504424A]
Patent IE-40054-L (IE)
Title: Treating phosphated mild steel
IPC: C23C2/06
Filed: 1974-10-04
Abstract: 1418966 Treating phosphated steel CIBAGEIGY AG 7 Oct 1974 [6 Oct 1973] 46794/73 Heading C7U Phosphated mild steel is contacted with a solution containing a compound in which R<SP>1</SP> is an aryl or substituted aryl grouping each of 6-20 C atoms, or alkyl with up to 6 C, R<SP>2</SP> is H or R<SP>1</SP> and R<SP>2</SP> together form a 6-membered carbocyclic ring, R<SP>3</SP> is H or an acyl grouping containing 2 or 3 C atoms and R<SP>4</SP> is a straight or branched alkyl grouping containing up to 20 C atoms, cycloalkyl containing 5 or 6 C atoms, an aralkyl or substituted aralkyl grouping or an aralkylene phosphonic acid grouping containing up to 20 C atoms, A is a saturated divalent alkylene radical containing up to 6 C atoms, X= PO 3 H 2 or PO 2 H 2 and m = 0, 1 or 2 and n is 0 or 1, or a water soluble salt thereof. Said salt may be a Na, K, NH 4 or triethanolamine salt, the steel may have a zinc- or ferric phosphate coating, and application is by spraying or immersion, to enhance corrosion resistance.
[GB1418966A]
Patent IE-822220-L (IE)
Title: Semi-conductor integrated circuit with interconnecting¹layers
IPC: H01L21/76
Filed: 1982-09-10
Abstract: Methods for the production of semiconductor devices having elements fabricated in element fabrication areas of a semiconductor substrate surrounded by buried insulating layers, wherein an improvement is realized by the introduction of a series of steps including a step to interleave a thermal strain absorbing layer between the top surface of a semiconductor substrate and an insulating layer of which a part is scheduled to become a buried insulating layer, for the purpose to allow the thermal strain absorbing layer to absorb strains which may otherwise occur due to an annealing process and to prevent damages which may otherwise be produced by irradiatior of ion beams, from being produced. 
[EP0074541A2]
Patent IE-792225-L (IE)
Title: Electric cell
IPC: H01M4/58
Filed: 1979-11-21
Abstract: The invention relates to a solid positive active material for electric cells whose negative active material is an alkali metal. In accordance with the invention, said positive material is a compound formed by two oxides, namely, bismuth oxide Bi2O3 and cupric oxide CuO. Application to lithium cells.
[US4268588A]
Patent IE-902333-L (IE)
Title: Process
IPC: C07D521/00
Filed: 1990-06-27
Abstract: The invention relates to a process for reducing the crystal size of ondansetron hydrochloride dihydrate produced by crystallisation from solvent to a size which is suitable for effective distribution in a tablet blend, in particular 100% less that 250 mu m. The ondansetron hydrochloride dihydrate is desolvated by drying at elevated temperature and reduced or atmospheric pressure and is then rehydrated.
Patent IE-44471-L (IE)
Title: Stabilized erythrocytes and their use
IPC: G01N33/49
Filed: 1976-11-12
Abstract: Stable lyophilisable erythrocyte preparations are obtained by treating erythrocytes which are suspended in aqueous isotonic solutions with a lower aliphatic aldehyde and a water-soluble salt of 2- or 3-valent chromium. The treatment with aldehyde and the chromium salts can take place successively in any desired sequence or simultaneously. The treated erythrocytes are washed and, if required, lyophilised. The resulting stabilised erythrocyte preparations can be coated with antigen and antibodies too. The coated erythrocytes can be employed for haemagglutination tests.
[GB1563839A]
Patent IE-842801-L (IE)
Title: Thermal insulating material.
IPC: C08L97/00
Filed: 1984-10-31
Abstract: A solid and dimensionally stable thermal insulating materials is provided by filling some or all of the voids which occur in expanded corkboard with a polymer foamed, preferably, in situ. The filled corkboard may also have a layer of foamed polymer bonded thereto, and the outer surface may be provided with a skin of sheet material. The material may also be given a waterproofing treatment and the polymer may contain an additive to improve serviceability.
Patent IE-883347-L (IE)
Title: Imidazoquinoxaline compounds and their preparation and use
IPC: C07D471/14
Filed: 1988-11-07
Abstract: New imidazoquinoxaline compounds having the formula <CHEM>  wherein X is CH, Chalogen or N; and R<3> is <CHEM>  or CO2R min wherein R min  is C1-6 alkyl, C3-7 cycloalkyl or (C1-6 alkoxy)methyl are useful in psychopharmaceutical preparations as anticonvulsants, anxiolytics and hypnotics, and in improving the cognitive function of the brain of mammals.
Patent NO-781681-L (NO)
Title: Svivelkopling.
Inventor: TAYLOR DONALD F
IPC: E21B17/08
Filed: 1978-05-12
Abstract: Svivelkopling.
Patent NO-823865-L (NO)
Inventor: ASPISI CHRISTIAN
IPC: C08F20/52
Filed: 1982-11-18
Abstract: The invention relates to new reticulated statistic acrylic copolymers that may be used in a very wide range of solvents (water, methylene chloride, chloroform, methanol, ethanol, dimethylformamide, pyridine,) stable between pH 1 and pH 14, to preparation process thereof and to their use in ion exchange chromatography.
Patent NO-843961-L (NO)
Inventor: BAUMAN DALE ELTON
IPC: A61K38/27
Filed: 1984-10-02
Abstract: This invention relates to the administration of growth hormone to a ruminant between about the onset of puberty to about first parturition, thereby increasing the quantity of mammary parenchyma, resulting in increased milk production during subsequent lactations.
Patent NO-852091-L (NO)
Inventor: HOFF CHRISTIAN
IPC: C07D489/00
Filed: 1985-05-24
Abstract: 1. A process for the dealkylation of 14-hydroxymorphinan alkaloids, characterized in that it consists in : 1) reacting the 14-hydroxy derivative of the formula :  see diagramm : EP0164290,P5,F6  in which R' is CH3 or COCH3 , with excess ethyl chloroformate, in the presence of potassium carbonate and in a solvent, 2) subjecting the resulting carbamate of the formula :  see diagramm : EP0164290,P5,F2  in which R' is CH3 or COCH3 , to hydrolysis in a strong acid medium to give the corresponding dealkylated derivative of the formula :  see diagramm : EP0164290,P5,F3  in which R is CH3 or hydrogen.
Patent NO-862031-L (NO)
Inventor: MACHATE RAINER
IPC: A47C/
Filed: 1986-05-22
Abstract: A chair having a seat member rotatably supported about a swivel point in the region of its front edge relative to a seat carrier. The chair also has a back member connected to at least one lever which is pivotally supported on the seat carrier. The lever is connected so that in the case of an inclination of the back member there simultaneously occurs in a predetermined relationship an inclination of the seat member so that the area of the seat back in the region of the user's lumbar vertebra is changed in such a way that the support is at an optimum during each inclined position of the seat back. A control member is hingedly connected at one end to the back member below the point of its engagement with the lever. The control member is hingedly connected to the seat carrier or to the seat at its other end in a first pivot axle spaced from a second pivot axle of the lever on the seat carrier. The lever and the control member are hingedly connected with one another by means of a connecting element, so that a relative movement between the lever and the control member in the coupling point or between the control member and its connecting point on the seat carrier or on the seat can occur.
Patent NO-870020-L (NO)
Inventor: ISMAIL IBRAHIM A
IPC: C12Q1/28
Filed: 1987-01-05
Abstract: A stable test device for the determination of a peroxidatively active substance comprising a carrier containing 1,4-diisopropylbenzene dihydroperoxide and a benzidine indicator in a molar ratio of from 0.9 to 3.0. The composition can be incorporated with a carrier matrix with a ferric chelate to provide ascorbate resistance, important in a urine test for occult blood. The test device is stable under storage and heat stress and can be used to prepare a multitest strip containing a glucose test based on a peroxidase/potassium iodide indicator system.
Patent NO-880297-L (NO)
Inventor: CHEN YUHPYNG LIANG
IPC: C07D235/00
Filed: 1988-01-25
Abstract: Antibacterial penicillins of the formula <CHEM> or a pharmaceutically acceptable salt thereof wherein R<1> is a heterocyclic group and R is hydrogen, the residue of certain carboxy protecting groups or the residue of an ester group readily hydrolyzable in vivo having activity against resistant organisms.
Patent NO-885046-L (NO)
Inventor: BOULE JEAN-PIERRE
IPC: H04M11/08
Filed: 1988-11-11
Abstract: The securing of data exchange between a teletext terminal (TVX) and a host (SE) is done with the aid of an additional box (BA) connected to the computer-peripheral port (PPI) of the terminal (TVX). In a pre- session mode, the box acts on the switching element (AIG) of the terminal (TVX) whilst monitoring all other action on this switching element; the box and the host communicate in accordance with a predetermined sequence of operations comprising the definition of a session key which is transmitted or ciphered in accordance with a basic key. Any anomaly during this communication causes the aborting of the pre-session mode. 
<IMAGE>
Patent NO-885095-L (NO)
Inventor: GASKILL GAROLD B
IPC: H04W84/02
Filed: 1988-11-15
Abstract: Improved time-division multiplexed communication methods for a wide area paging system. One method appends check bits of a correction code to each data word and interleaves the words on transmission. A second method transmits multiple messages for one or more paging receivers in a single time slot. A third method increases the number of individual receivers that can be served by a single paging system. A fourth method increases the number of receivers that can be served by splitting the receivers in an area among several systems.
Patent NO-890226-L (NO)
Inventor: SOMMER OSWIN
IPC: C08L83/04
Filed: 1989-01-18
Abstract: The organopolysiloxane compositions are stabilised by salts of main group or subgroup 2 with branched carboxylic acids having 5 to 15 carbon atoms.
Patent NO-903058-L (NO)
Inventor: UESUGI KEIZO
IPC: A61K31/405
Filed: 1990-07-09
Abstract: A pharmacological composition for soft capsules, comprises a polyprenyl compound having the formula (1) and a surfactant and/or an unsaturated aliphatic acid, improved in absorbability. <CHEM> wherein n represents 1 to 3,
Patent NO-903830-L (NO)
Inventor: SAWADA TAKASHI
IPC: G01N33/531
Filed: 1990-09-03
Abstract: The assay method comprises the steps of adding a serum specimen to a solid phase at a pH value of 9 to 10 and assaying an antibody in the specimen. The antibody may be adult T cell leukemia virus antibody (HTLV-I antibody).
Patent NO-910261-L (NO)
Title: Mobilradiosystem.
Inventor: HEIDEMANN ROLF
IPC: H04B10/12
Filed: 1991-01-23
Abstract: Mobi 1 radiosystem med en sentral og med basestasjoner, hvor basestasjonene (FSi til FS) sender og mottar radiosignaler til og fra mobile abonnenter (MS). Radios ignalene blir i henhold til foreliggende oppfinnelse ikke som vanlig generert, henholdsvis bearbeidet, i basestasjonene, men i sentralen (1).Sentralen (1) inneholder også en mikrobølgesender/-mottager (SE i til SE) for hver basestasjon (F S i til FS), og denne sender/mottager omformer signalene som skal sendes til basestasjonen til radiosignaler og signalene som mottas fra basestasjonene til basisbåndet.Dette gir den fordel at bærebølge-innretningen kan være felles for mange basestasjoner, slik at kostnadene til systemet reduseres.
Patent NO-911076-L (NO)
Inventor: FRAZZA MARK STEPHEN
IPC: C08F/
Filed: 1991-03-19
Abstract: A process for making uniformly sized polymer particles, having a final particle size of 1-50 micron, comprises (a) combining sufficient free-radical-polymerisable, water-insoluble monomer, or mixt thereof, with an aq dispersion of seed polymer particles, at a rate such that the amt of monomer(s) equal to the total initial wt of the seed polymer particles is combined with the dispersion over 45-120 (pref 60-90) mins, in the presence of a dispersion stabiliser and an oil-soluble, free-radical polymsn initiator. The temp is at least high enough to activate the initiator, and (b) maintaining the temp until polymsn is complete. Opt these steps are repeated until the required final particle size is achieved